Spending power
TheGrid Corporate Spending Power index would rate purchasing capacity from registry, scale and activity signals.
Spending power
Brand profile · Hospitals and Health Care
Cholangiocarcinoma Foundation is a Hospitals and Health Care brand in Gold Coast, Queensland. It is a nonprofit, and its site is cholangio.org. It holds one address on record, all in Australia. Headcount on record is 4. One Australian registration (ABN) is a confirmed match. It is listed alongside six similar brands, mostly in Higher Education.
ABN93665038102
| CHOLANGIOCARCINOMA FOUNDATION AUSTRALIA PTY LTD | ABN 93665038102 |
|---|---|
| Confirmed matches | 0 of 1 |
A candidate is a name match on the registry, not a confirmed identity, and two candidates are ambiguity rather than a corporate structure.
Cholangiocarcinoma Foundation Australia Cholangiocarcinoma is bile duct cancer.
The Foundation is a patient-led cancer advocacy and research organisation transforming the response to bile-related cancers, including cholangiocarcinoma, liver, gallbladder, pancreatic, and duodenal cancers.
Co-founded by Stage IV survivor Steve Holmes, the foundation pioneers a structured, patient-driven response strategy, shifting the culture from passive care to a proactive, high-performance response model.
Advocacy Beyond Awareness—Driving Real Solutions We stand shoulder-to-shoulder with patients at the coalface because we are patient-led.
We replace the traditional boardroom advocacy model of slick, awareness-driven charity campaigns with execution over awareness, action over messaging, and measurable survival impact over marketing.
We bridge the gap between patients, clinicians, researchers, and industry, ensuring today’s breakthroughs reach today’s patients—where it matters most—survival at the coalface.
Mission ✔ Empower the Patient → Increase Survival.
✔ Empower Their Community → Exponentially Increase Survival.
Focus ✔ Empowering Patients & Caregivers at the Clinical Level – Ensuring every patient is equipped with a structured response strategy before leaving the diagnosing phase, maximising their ability to engage in effective treatment from Day 1.
✔ Simplify to Survive – Simplification → Understanding → Engagement → Effective Response → Increased Survival.
Cancer is complex. Survival should not be.
✔ Transforming Cancer Culture – Shifting from passive care to a proactive, high-performance response model.
✔ Optimising Patient Response Strategies – Continually innovating structured frameworks, response strategies, and decision-making processes to maximise survival outcomes.
✔ Aligning & Strengthening Communities – Building interconnected patient, clinical, and research ecosystems that capitalise on and elevate lived experience.
✔ NGS Integrations & Precision Medici
| Countries | 1 |
|---|---|
| Primary country | AU |
All codes: AU
TheGrid Corporate Spending Power index would rate purchasing capacity from registry, scale and activity signals.
Spending power
Hiring, headcount and registry-change signals, streamed to members.
Registry-filed capital and financial indicators, standardised by TheGrid.
3 employee profiles on record · names withheld.
Names and titles are intentionally absent from this page. The source relation carries no consent record across the privacy regimes this directory spans, so it is never requested and never stored. Search engines see exactly what you see here.
Names are withheld until a consented source exists.
One Queensland entity on the ABR: CHOLANGIOCARCINOMA FOUNDATION AUSTRALIA PTY LTD (ABN 93 665 038 102), high confidence.
4 counted staff profiles at January 2026, inside the self-reported 2–10 band.
One address on record, Australia only. Primary: Gold Coast, Queensland 4217.
None linked to this brand.
3 profiles list Cholangiocarcinoma Foundation Australia as a peer. It lists ten peers of its own. Murdoch University School of Medical, Molecular and Forensic Sciences and Limbs 4 Life list it back.